The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jacob R,Bledsoe

第一单位： Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

作者： Jacob R,Bledsoe ^[1] ; Robert A,Redd ^[2] ; Robert P,Hasserjian ^[1] ; Jacob D,Soumerai ^[3] ; Ha T,Nishino ^[4] ; Daniel F,Boyer ^[5] ; Judith A,Ferry ^[1] ; Lawrence R,Zukerberg ^[1] ; Nancy Lee,Harris ^[1] ; Jeremy S,Abramson ^[6] ; Aliyah R,Sohani ^[7]

作者单位： Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. ^[1] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. ^[2] Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York. ^[3] Department of Pathology, North Shore Medical Center, Salem, Massachusetts. ^[4] Department of Pathology, University of Michigan, Ann Arbor, Michigan. ^[5] Center for Lymphoma, Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts. ^[6] Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. arsohani@partners.org. ^[7]